Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Sep;127(10):1180-1188.
doi: 10.1111/1471-0528.16238. Epub 2020 May 17.

Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis

H T Wolf  1 , L D Huusom  1 , T B Henriksen  2   3 , H K Hegaard  4 , J Brok  5 , A Pinborg  6
Affiliations
Meta-Analysis

Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis

H T Wolf et al. BJOG. 2020 Sep.

Abstract

Background: Ordinary meta-analyses indicate that magnesium sulphate (MgSO4 ) treatment in women at imminent risk for preterm delivery decreases the offspring's risk of cerebral palsy (CP). However, repetitive testing of cumulative data calls for statistical caution, e.g. by trial sequential analysis (TSA), for which there are previously insufficient samples to draw a firm conclusion. Recently, a randomised controlled trial (RCT) provided additional data that potentially increased the sample size such that a new TSA might detect a statistically significant effect.

Objectives: To assess the possible fetal neuroprotective effect of MgSO4 for women at imminent risk for preterm delivery in an updated systematic review with meta-analysis and TSA.

Search strategy: We searched MEDLINE, Embase, Cochrane and ClinicalTrials.gov on 8 October 2019. The search strategy clustered terms describing the MgSO4 intervention and preterm delivery.

Selection criteria: RCTs.

Data collection and analysis: Two reviewers extracted the data. Summary relative risks (RRs) and 95% confidence intervals (CIs) were calculated using fixed-effects models. A TSA was applied to the primary outcome, CP. The quality of the evidence was assessed using GRADE. The protocol was registered in PROSPERO (registration: CRD42019151441).

Main results: We identified six eligible trials (5917 women). MgSO4 intervention in women at imminent risk for preterm birth decreased the offspring's CP risk (meta-analysis RR 0.68, 95% CI 0.54-0.85; TSA RR 0.69, 95% CI 0.48-0.97).

Conclusions: This systematic review with meta-analysis and TSA shows conclusively that MgSO4 , when given to women at imminent risk for preterm delivery, decreases the offspring's CP risk.

Tweetable abstract: Antenatal magnesium sulphate decreases the risk of cerebral palsy in children born preterm.

Keywords: Cerebral palsy; MgSO4; magnesium sulphate; meta-analysis; neuroprotection; preterm delivery; systematic review; trial sequential analysis.

PubMed Disclaimer

References

    1. LiuL, JohnsonHL, CousensS, PerinJ, ScottS, LawnJE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet2012;379:2151-61.
    1. SaigalS, DoyleLW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet2008;371:261-9.
    1. GariteTJ, CombsCA. Obstetric interventions beneficial to prematurely delivering newborn babies: antenatal corticostetroids, progesterone, magnesium sulfate. Clin Perinatol2012;39:33-45.
    1. WolfHT, HegaardHK, GreisenG, HuusomL, HedegaardM. Treatment with magnesium sulphate in pre-term birth: a systematic review and meta-analysis of observational studies. J Obstet Gynaecol2012;32:135-40.
    1. DoyleLW, CrowtherCA, MiddletonP, MarretS, RouseD. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane database Syst Rev2009:CD004661.

Publication types